The China orthopedic biomaterial market is on an upward trajectory, with insights revealing the dynamics behind its market share expansion. Currently valued at 532.5 million USD, the market is forecasted to experience substantial growth, reaching 1,312 million USD by 2035, with a CAGR of 5.01%. This growth is indicative of a broader trend towards advanced orthopedic solutions that meet the...